Antiparkinsonian drugs can be classified as dopaminergic and non-dopaminergic drugs. Dopaminergic drugs include levodopa, dopamine agonists, monoamine oxidase
Antiparkinsonian drugs can be classified as dopaminergic drugs and non-dopaminergic drugs. Dopaminergic drugs mainly work as modulating dopaminergic transmission. Here the precursor of dopamine, levodopa, dopamine agonists, monoamine oxidase B (MAOB) inhibitors, catechol-O-methyltransferase (COMT) inhibitors, and zonisamide are classified. Non
Antiparkinsonian drugs can be classified as dopaminergic and non-dopaminergic drugs. Dopaminergic drugs include levodopa, dopamine agonists, monoamine oxidase B inhibitors, catechol-O-methyltransferase inhibitors, and zonisamide.
Antiparkinsonian drugs can be classified as dopaminergic and non-dopaminergic drugs. Dopaminergic drugs include levodopa, dopamine agonists, monoamine oxidase
classes of antiparkinsonian drugs Several drugs are used for treatment of PD and classified into dopaminergic and nondopaminergic. The dopaminergic drugs include levodopa, dopaminergic agonists (DA), monoamine oxidase-B enzyme (MAO-B) inhibitors, and catechol-ortho-methyltransferase (COMT) inhibitors.
Antiparkinsonian drugs can be classified as dopaminergic and non-dopaminergic drugs. Dopaminergic drugs include levodopa, dopamine agonists
Commonly used dopaminergic agents include levodopa and carbidopa. Dopamine agonists: Similar to dopaminergic agents, dopamine agonists raise
Antiparkinsonian drugs can be classified as dopaminergic and non-dopaminergic drugs. Dopaminergic drugs include levodopa, dopamine agonists, monoamine oxidase
Antiparkinsonian drugs can be classified as dopaminergic and non-dopaminergic drugs. Dopaminergic drugs include levodopa, dopamine agonists, monoamine oxidase B inhibitors, catechol-O-methyltransferase inhibitors, and zonisamide.
Comments